Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical models
Laura J. Janke(St. Jude Children's Research Hospital), Seth E. Karol(St. Jude Children's Research Hospital), David Jenkins(Manchester Academic Health Science Centre), Emily R. Finch(St. Jude Children's Research Hospital), Monique A. Payton(St. Jude Children's Research Hospital), Yiwei Liu(Tianjin University of Technology), Xiangjun Cai(Shenyang 242 Hospital), Mary V. Relling(St. Jude Children's Research Hospital)
Cited by 16
Related Papers
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
|New England Journal of Medicine|2009|1.2k
Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2004|1.2k